Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Blau

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Archives of Neurology|June 1, 1980
The not-so-benign Miller Fisher syndrome: a variant of the Guilain-Barré syndromeI Blau, I Casson, A Lieberman, et al.
Journal of Clinical Psychology|July 1, 1990
Willingness to apply understood ethical principlesM A Wilkins, J M McGuire, D W Abbott, et al.
Bone Marrow Transplantation|August 10, 2000
New strategies in GVHD prophylaxisM G Kiehl, M Shipkova, N Basara, et al.
Psychological Reports|August 1, 1994
Bulimia: an empirical analysis of psychodynamic theoryM J Herkov, R A Greer, B I Blau, et al.
Clinical Transplantation|April 19, 2000
Mycophenolate mofetil for the prophylaxis of acute GVHD in HLA-mismatched bone marrow transplant patientsN Basara, W I Blau, M G Kiehl, et al.
Bone Marrow Transplantation|July 25, 1998
Mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant patientsN Basara, W I Blau, E Römer, et al.
Experimental Hematology|April 27, 2005
Mesenchymal stem cells remain of host origin even a long time after allogeneic peripheral blood stem cell or bone marrow transplantationKathrin Rieger, Olga Marinets, Thomas Fietz, et al.
British Journal of Cancer|July 28, 2011
Docetaxel and capecitabine for advanced gastric cancer: investigating dose-dependent efficacy in two patient cohortsP C Thuss-Patience, A Kretzschmar, Y Dogan, et al.
Annals of Hematology|May 6, 2004
Treosulfan/fludarabine: a new conditioning regimen in allogeneic transplantationJ Casper, W Knauf, I Blau, et al.
Clinical Genetics|April 5, 2016
A role for TENM1 mutations in congenital general anosmiaA Alkelai, T Olender, R Haffner-Krausz, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Archives of Neurology|June 1, 1980
The not-so-benign Miller Fisher syndrome: a variant of the Guilain-Barré syndromeI Blau, I Casson, A Lieberman, et al.
Journal of Clinical Psychology|July 1, 1990
Willingness to apply understood ethical principlesM A Wilkins, J M McGuire, D W Abbott, et al.
Bone Marrow Transplantation|August 10, 2000
New strategies in GVHD prophylaxisM G Kiehl, M Shipkova, N Basara, et al.
Psychological Reports|August 1, 1994
Bulimia: an empirical analysis of psychodynamic theoryM J Herkov, R A Greer, B I Blau, et al.
Clinical Transplantation|April 19, 2000
Mycophenolate mofetil for the prophylaxis of acute GVHD in HLA-mismatched bone marrow transplant patientsN Basara, W I Blau, M G Kiehl, et al.
Bone Marrow Transplantation|July 25, 1998
Mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant patientsN Basara, W I Blau, E Römer, et al.
Experimental Hematology|April 27, 2005
Mesenchymal stem cells remain of host origin even a long time after allogeneic peripheral blood stem cell or bone marrow transplantationKathrin Rieger, Olga Marinets, Thomas Fietz, et al.
British Journal of Cancer|July 28, 2011
Docetaxel and capecitabine for advanced gastric cancer: investigating dose-dependent efficacy in two patient cohortsP C Thuss-Patience, A Kretzschmar, Y Dogan, et al.
Annals of Hematology|May 6, 2004
Treosulfan/fludarabine: a new conditioning regimen in allogeneic transplantationJ Casper, W Knauf, I Blau, et al.
Clinical Genetics|April 5, 2016
A role for TENM1 mutations in congenital general anosmiaA Alkelai, T Olender, R Haffner-Krausz, et al.
Pageof 2